Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes

Table 1

Death and repeat revascularization at five years with CABG and stenting.

Study Name	CABG versus Stenting
	Rate of repeat revascularization	Death
ERACI-II	7.2% versus 28.4%, P = 0.0002	11.5% versus 7.1%, P = 0.182
ARTS	8.8% versus 30.3%, 𝑃<0.001	7.6% versus 8.0%; P = 0.83
SOS	6.0% versus 20.7%, 𝑃<0.001*	4.3% versus 8.1%; P = 0.016

*Clinical outcomes at median followup of 02 years.